“With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management solution that is both accessible and affordable,” said Interim Chief Executive Tara Comonte in prepared remarks.
Source link
WeightWatchers’ stock soars after adding compounded GLP-1 treatment to its offering
Date:
Share post:
